Effect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985-2009 by Hulman A, et al.
Original article
Effect of secular trends on age-related
trajectories of cardiovascular risk factors: the
Whitehall II longitudinal study 1985–2009
Adam Hulma´n,1* Adam G Taba´k,2,3 Tibor A Nya´ri,1 Dorte Vistisen,4
Mika Kivima¨ki,2 Eric J Brunner2 and Daniel R Witte5
1Department of Medical Physics and Medical Informatics, University of Szeged, Szeged, Hungary,
2Department of Epidemiology and Public Health, University College London, London, UK, 3First Depart-
ment of Medicine, Semmelweis University Faculty of Medicine, Budapest, Hungary, 4Steno Diabetes
Center, Gentofte, Denmark and 5Centre de Recherche Public de la Sante´, Strassen, Luxembourg
*Corresponding author. Department of Medical Physics and Medical Informatics, University of Szeged, H-6720 Szeged,
Kora´nyi fasor 9, Hungary. E-mail: hulman.adam@med.u-szeged.hu
Accepted 18 December 2013
Abstract
Background: Secular trends in cardiovascular risk factors have been described, but few
studies have examined simultaneously the effects of both ageing and secular trends
within the same cohort.
Methods: Development of cardiovascular risk factors over the past three decades was
analysed using serial measurements from 10 308 participants aged from 35 to 80 years
over 25 years of follow-up from five clinical examination phases of the Whitehall II study.
Changes of body mass index, waist circumference, blood pressure and total and high-
density lipoprotein cholesterol distribution characteristics were analysed with quantile
regression models in the 57–61 age group. Age-related trajectories of risk factors were
assessed by fitting mixed-effects models with adjustment for year of birth to reveal secu-
lar trends.
Results: Average body mass index and waist circumference increased faster with age
in women than in men, but the unfavourable secular trend was more marked in men.
Distributions showed a fattening of the right tail in each consecutive phase, meaning a
stronger increase in higher percentiles. Despite the higher obesity levels in younger birth
cohorts, total cholesterol decreased markedly in the 57–61 age group along the entire
distribution rather than in higher extremes only.
Conclusion: The past three decades brought strong and heterogeneous changes in car-
diovascular risk factor distributions. Secular trends appear to modify age-related trajecto-
ries of cardiovascular risk factors, which may be a source of bias in longitudinal
analyses.
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Introduction
Cardiovascular disease (CVD) remains the most common
cause of death in the UK. Despite the fact that CVD mor-
tality in the UK has halved during the past three decades, it
still accounts for approximately 30% of total mortality.1
A very similar situation is seen on a global scale,2 mostly
driven by the combination of ageing populations, seden-
tary lifestyle and high-calorie diets. Many CVD risk factors
are increasingly controlled or treated (e.g. smoking, obes-
ity, hypertension, diabetes, hypercholesterolaemia) in peo-
ple at the high end of the risk distribution, and in many
countries population-based campaigns have been put in
place to promote a healthier lifestyle.
The combined effects of societal trends that increase
CVD risk factors and the individual and population-based
efforts to mitigate them have been different for different
risk factors. Although systolic blood pressure and choles-
terol levels have decreased markedly in high-income coun-
tries in the past decades,3–9 the obesity ‘epidemic’ seems to
continue unabated.10–17
Much of the evidence on the trends in cardiovascular
risk comes from the comparison of observed average
risk factor levels in sequential cross-sectional surveys, and
only few of these studies have investigated trends in the
most important CVD risk factors within the same
population.7,8
A second aspect that has received little attention is the
change in cardiovascular risk factor distributions. This
issue may have important practical implications because
the Rose prevention paradigm, which has strongly affected
public health policy in the past decades, assumes that as
populations move into higher CVD risk levels, risk factor
distributions shift in their entirety to the right. Hence, pre-
vention of CVD events should target the entire popula-
tion.18,19 However, few studies have examined whether
the shift of CVD risk factor distributions indeed follows
these assumptions. The limited evidence available for BMI
suggests that the distribution has become increasingly
skewed in the past decades, with little upward shift of the
entire curve.20–22
To address these issues, we investigated the develop-
ment of body mass index (BMI), waist circumference
(WC), systolic and diastolic blood pressure (SBP and DBP),
and total and high-density lipoprotein cholesterol (TC and
HDL) over 25 years in a British occupational cohort, the
Whitehall II study. Our aim was to determine whether (i)
changes over time were similar along the full range of risk
factor distributions, and whether (ii) age-related trajecto-
ries were affected by secular trends.
Methods
Study setting
Between 1985 and 1988, 10 308 British men and women
(73% of those invited), aged 35–55 years and employed in
London-based government departments, participated in
the first phase of the Whitehall II study.23 Two thirds of
them were men. Clinical examinations in addition to postal
questionnaires were part of every second phase, i.e. phase
1 in 1985–88, phase 3 in 1991–94, phase 5 in 1997–99,
phase 7 in 2002–04 and phase 9 in 2007–09. The final
dataset contained up to five repeated measurements per
participant.
Measurements
BMI was calculated as the ratio of weight (in kg) and
height-squared (in m2). WC (smallest) was first measured
at phase 3. All anthropometric measures were assessed by
trained nurses according to standardized protocols. Sys-
tolic and diastolic blood pressures were measured twice at
each clinical phase and the average was used in the ana-
lyses. After phase 5, the manual random zero sphygmo-
manometer (MRZ) was switched to an automated
oscillometric device (AOD). The biochemical analysis of
blood samples to assess total and HDL cholesterol values
Key Messages
• In recent years more people have high body mass index and waist circumference and fewer people have average val-
ues, but the proportion of people with low values has not changed.
• Whereas both systolic and diastolic blood pressure levels have declined in the past decades, diastolic blood pressure
has done so more markedly, leading to an increasing pulse pressure.
• In the past decades total cholesterol levels have dropped in the entire population.
• Descriptions of risk factor trends focusing only on mean levels lack detail with regard to changing distributions.
• Secular trends should be taken into account when analysing age-related trajectories of risk factors to avoid biased es-
timates caused by large differences between successive birth cohorts.
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is described in details elsewhere.24 The University College
London ethics committee reviewed and approved the
study. Written informed consent was obtained from all
participants at each study phase.
Statistical analyses
To describe secular trends, 10th, 50th and 90th percentiles
of risk factors were calculated for the 57–61 age group at
each of the last four phases (this age group was not repre-
sented in phase 1 when the participants were at 35–55
years of age). This resulted in an 18-year long study period
for this sequential cross-sectional analysis. We investigated
whether trends were similar across the full range of the dis-
tribution of each cardiovascular risk factor. A linear trend
was estimated with quantile regression using calendar year
as the explanatory variable. Non-parametric smooth ker-
nel distributions were fitted to get an overall picture of
how the characteristics (location and shape) changed from
phase to phase.
Quadratic age-related risk factor trajectories for the
mean were assessed with mixed-effects models with random
intercepts. We added year of birth and its interaction terms
with age and age-squared to the models to analyse secular
trends. To test the robustness of our results against selective
loss of follow-up and healthy survival, we fitted models to a
subgroup who participated up to phase 9 (not necessarily in
each phase) in a sensitivity analysis. Statistical analysis was
performed using Mathematica 9 (Wolfram Research) and R
version 2.15.1 (lme4, quantreg and Epi packages).
Results
Cohort characteristics
Baseline characteristics are shown in Table 1. Women were
more likely to be current smokers than men. Almost half of
the women had the lowest employment grade, whereas this
was the case only in 1 in 10 men. The largest sex differences
in cardiovascular risk factors were in WC and HDL.
The number of participants at each phase is displayed in
Table 2. Relatively fewer men (31.0%) than women
(41.3%) were lost (caused by either death or non-response/
withdrawal) from the study until phase 9. Attrition was
largest between phase 1 and 3 (12.8%). The average num-
ber of visits per participant was 4.
Sequential cross-sectional analyses (age group:
57–61 years)
Table 3 displays cardiovascular risk factor percentiles
(10th, 50th, 90th) in the 57–61 age group at study phases
3, 5, 7 and 9. Smooth kernel distributions are shown in
Figure 1.
The BMI distribution of men not only shifted to the
right (except for extremely low percentiles) but also be-
came more fat-tailed on the right. The increment was
larger in higher percentiles (the 90th percentile increased
by 2.8 kg/m2 between phases 3 and 9), which led to a
higher degree of skewness. The change in women showed a
slightly different pattern. A larger part of the distribution’s
left end (below 23 kg/m2) remained unchanged, but a fat-
tail grew on the right end (the 90th percentile increased by
2 kg/m2). Contrarily to BMI, WC increased also in the
10th percentile, but the changes were the largest in the
right end of the distribution with an 8-cm increment be-
tween 1991 and 2009 in both men and women.
SBP measures slightly increased until phase 7, but
dropped markedly at the last phase. The entire DBP distri-
bution shifted to the left by 10 mmHg in men. In women,
the decline was larger in the 10th percentile than in the
90th (10 mmHg vs 6 mmHg).
There was a marked distribution shift to the left in TC.
The median decreased by 22% in both men and women.
This 1.5-mmol/l decline characterized the entire distri-
bution, although the 90th percentile decreased even more
(1.9 mmol/l) in women. The changes in the HDL distri-
bution were modest compared with our observations
in TC, although all calculated percentiles increased by
0.1–0.2 mmol/l.
Changes in smoking habits and medication usage are
shown in Table 4. The percentage of current smokers
Table 1. Baseline characteristics (1985–88). Values are me-
dians (Q1; Q3) or percentages (%)
Characteristic Men (N¼6895) Women (N¼3413)
Age (year) 43 (39; 49) 45 (40; 51)
Whites (%) 91.5 84.2
Smoking (%)
Never 47.3 52.9
Ex 36.1 23.3
Current 15.8 23.3
Missing 0.8 0.5
Grade level (%)
Administrative 38.4 11.2
Prof/executive 52.3 39.1
Clerical/support 9.3 49.7
BMI (kg/m2) 24.3 (22.6; 26.2) 24.0 (21.9; 26.7)
WC (cm)a 88.9 (83.0; 94.7) 76.5 (69.5; 85.4)
SBP (mmHg) 123 (115; 133) 118 (109; 130)
DBP (mmHg) 77 (71; 84) 75 (68; 81)
TC (mmol/l) 5.9 (5.2; 6.7) 5.8 (5.1; 6.6)
HDL (mmol/l) 1.3 (1.1; 1.6) 1.6 (1.4; 2.0)
aWC values are from phase 3, when first measured.
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remained constant at 8% in men, but decreased mark-
edly in women. Usage of lipid-lowering medication
increased drastically in both men and women. Whereas at
phase 3 only 1–2% took medication, at phase 9 every
fourth man and fifth woman did so. Around 25% of par-
ticipants were on antihypertensive medication at phase 9.
Longitudinal analyses
Age-related mean risk factor trajectories for the entire
study population are displayed in Figure 2. The age range
of 57–61 years is highlighted to visualize the subset of par-
ticipants used for the quantile regression analyses. Model
coefficient estimates are displayed in eTable 1 (available as
Supplementary data at IJE online).
Both BMI and WC increased faster in younger gener-
ations and were at higher levels than in older birth cohorts
at any given age {e.g. a BMI difference at age 60 between
those born in 1933 and 1948 of 1.3 kg/m2 [95% confi-
dence interval (CI) 1.1; 1.5] and 0.5 kg/m2 [95% CI 0.1;
0.9] for men and women, respectively}. The secular trend
in BMI was greater in men than in women, whereas
women in all birth cohorts had steeper BMI and WC tra-
jectories compared with men.
SBP increased faster with age in women than in men:
15.1 mmHg vs 8.9 mmHg, respectively, between ages 40
and 75 (12.9 % vs 7.2% relative difference). Younger gen-
erations, except men in late adulthood, had lower SBP lev-
els. The mean DBP trajectory (unadjusted) increased until
age 50, and then decreased markedly in both men and
women. The peaks of the adjusted DBP trajectories
occurred at earlier ages in younger generations, who also
had generally lower DBP levels: at age 60, men born in
1948 had a 8.4-mmHg (95% CI 7.8; 9.0) lower DBP than
men born in 1933, whereas for women this difference was
7.8 mmHg (95% CI 7.0; 8.7).
The unadjusted TC trajectory in men increased up to
age 47, peaking at 6.2 mmol/l (95% CI 6.2; 6.3) before
declining. For women the corresponding peak value was
6.3 mmol/l (95% CI 6.3; 6.4) at age 52. Men born in 1948
had 1.1-mmol/l (95% CI 1.0; 1.2) lower TC level at age
60, than men born in 1933, whereas for women the differ-
ence between these birth cohorts was 1.2 mmol/l (95% CI
1.1; 1.3). Women had higher HDL levels during the entire
age range under examination. We also observed a modest
positive trend and increment with ageing in both sexes.
In sensitivity analyses we fitted longitudinal models to a
subsample of participants who attended up to the last
phase, and we found associations very similar to those
described above (data not shown).
Discussion
We found that middle-aged British men and women expe-
rienced a marked change in cardiovascular risk over the
past 25 years, which was partly attributable to ageing and
partly due to secular trends. We report that at any given
age younger generations were more obese, but had a more
favourable lipid profile (i.e. lower total cholesterol levels
and higher HDL cholesterol levels). Furthermore, the
observed secular trends affected risk factor distributions.
Whereas the increase in obesity led to more right-skewed
distributions, the decrease in total cholesterol was charac-
terized by a left-shift of the entire distribution.
Obesity
We found evidence that changes in obesity were heteroge-
neous across the population between 1985 and 2009. Our
findings show that BMI increased particularly in groups
already affected by obesity, but also that although BMI did
not change in leaner groups, these were still developing ab-
dominal obesity. It is conceivable that as people become in-
creasingly sedentary, leaner people lose muscle mass and
simultaneously accumulate abdominal fat mass, leaving
their BMI unchanged while their WC increases. Given
the particular impact of central obesity on glucose metab-
olism25 and mortality26 independently of general obesity,
Table 2. Summary of participation status at each study phase. Number of participants and cumulative number of deaths and
non-responses/withdrawals are reported
Status Phase 1 1985–88 Phase 3 1991–94 Phase 5 1997–99 Phase 7 2002–04 Phase 9 2007–09
Men
Participated 6895 6057 5473 4893 4759
Died 81 204 389 621
Non-response / withdrawal 757 1218 1613 1515a
Women
Participated 3413 2758 2397 2074 2002
Died 44 102 195 333
Non-response / withdrawal 611 914 1144 1078a
aCumulative numbers may decrease, because we had information about the death of participants, even if they did not respond in a previous phase.
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Table 3A, B. Sequential cross-sectional analysis (age group: 57–61 years). Secular trends of cardiovascular risk factors in men
(A) and women (B). Linear trends were assessed with quantile regression models
A
Men Percentile Phase 3
1991–94
N5 911
Phase 5
1997–99
N5903
Phase 7
2002–04
N5 1222
Phase 9
2007–09
N51391
Linear trend (per year)
b (95% CI)
BMI (kg/m2)
10th 21.9 22.2 22.4 21.9 0.004 (0.014; 0.027)
50th 25.1 25.6 26.1 26.4 0.080 (0.065; 0.096)***
90th 29.1 30.4 31.8 31.9 0.192 (0.145; 0.234)***
WC (cm)
10th 78.4 80.3 81.2 80.6 0.152 (0.100; 0.210)***
50th 88.2 91.9 93.6 94.2 0.360 (0.318; 0.409)***
90th 101.4 105.2 108.4 109.6 0.508 (0.433; 0.631)***
SBP (mmHg)
10th 107 106 109 107 0.000 (0.086; 0.092)
50th 125 123 126 124 0.000 (0.031; 0.083)
90th 145 148 150 143 0.181 (0.313; 0.030)*
DBP (mmHg)
10th 71 65 61 60 0.654 (0.714; 0.603)***
50th 82 78 75 73 0.594 (0.653; 0.517)***
90th 95 91 89 85 0.577 (0.650; 0.490)***
TC (mmol/l)
10th 5.3 4.8 4.5 4.0 0.079 (0.085; 0.074)***
50th 6.7 5.9 5.7 5.2 0.083 (0.088; 0.077)***
90th 8.1 7.3 7.0 6.6 0.086 (0.093; 0.079)***
HDL (mmol/l)
10th 0.9 1.0 1.0 1.0 0.005 (0.003; 0.008)***
50th 1.3 1.3 1.4 1.4 0.008 (0.004; 0.010)***
90th 1.8 1.9 1.9 2.0 0.011 (0.009; 0.013)***
B
Women Percentile Phase 3
1991-1994
N5 520
Phase 5
1997-1999
N5 383
Phase 7
2002-2004
N5 492
Phase 9
2007-2009
N5 514
Linear trend (per year)
b (95% CI)
BMI (kg/m2)
10th 21.3 21.2 21.2 21.1 0.007 (0.043; 0.021)
50th 26.0 25.8 25.8 26.1 0.000 (0.023; 0.025)
90th 32.8 32.5 33.8 34.8 0.120 (0.063; 0.205)**
WC (cm)
10th 64.9 68.0 68.1 69.9 0.289 (0.190; 0.351)***
50th 78.4 80.0 81.0 83.0 0.276 (0.173; 0.391)***
90th 96.0 96.3 100.2 104.0 0.482 (0.354; 0.657)***
SBP (mmHg)
10th 104 103 104 99 0.277(0.406; 0.091)**
50th 122 123 123 116 0.350 (0.516; 0.202)***
90th 141 148 147 141 0.094 (0.141; 0.278)
DBP (mmHg)
10th 66 64 60 56 0.634 (0.707; 0.524)***
50th 78 75 72 69 0.558 (0.647; 0.491)***
90th 90 89 88 84 0.359 (0.464; 0.201)***
TC (mmol/l)
10th 5.8 4.9 4.7 4.4 0.084 (0.093; 0.071)***
50th 7.0 6.1 5.9 5.5 0.084 (0.093; 0.078)***
90th 8.8 7.6 7.3 6.9 0.115 (0.122; 0.098)***
HDL (mmol/l)
10th 1.2 1.2 1.3 1.3 0.009 (0.007; 0.010)***
50th 1.6 1.6 1.8 1.8 0.012 (0.010; 0.019)***
90th 2.3 2.2 2.5 2.5 0.015 (0.011; 0.023)***
N is the number of participants (aged 57–61 years) in each phase. Missing measures per variable do not exceed 3%, except phase 5 (BMI: 13%, WC: 20% and
HDL: 13%), when timing and organization issues took place at the screening (so we can assume that values are missing at random).
*P< 0.05; **P< 0.01; ***P< 0.001.
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our findings highlight the importance of assessing WC par-
ticularly among people with BMI levels in the normal or
overweight range.25
The global obesity ‘epidemic’ has been documented in
several countries, based on studies reporting mean BMI
levels17 or the prevalence of overweight and obesity.27 The
BMI distribution became more right-skewed between ado-
lescence and early adulthood28 and in adulthood20,21 in US
and Canadian populations.29 In addition, a Chinese popu-
lation-based study showed that the WC distribution shifted
to the right.22
As the marked increase in obesity in the UK seems to
lag behind the developments in North America, where the
most recent results show that the epidemic is levelling
off,30 it is conceivable that the right-skewing of the BMI
distribution we observed is a feature of the early dynamic
phase of the obesity epidemic, and that there is a point at
which the divergence of percentiles stabilizes.
Our analysis of BMI and WC trajectories showed that
in the past 25 years in the UK, each successive generation
has reached a set level of both obesity measures at an ear-
lier age. Participants born as little as 15 years apart (1948
compared with 1933) reached overweight at a 10-year ear-
lier age for men and a 6-year earlier age for women. It is
clear that the 1933 generation in the UK have had a very
different early life experience, spending their youth in the
A
Figure 1 A,B. Sequential cross-sectional analysis (age group: 57–61 years). Smooth kernel distributions of cardiovascular risk factors (probability
density functions are displayed) in men (A) and women (B) (dotted line: phase 3, dashed line: phase 5, solid line: phase 7, thick line: phase 9).
(continued)
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austerity of the 1930s and the war period, whereas the
1948 generation spent these same years in the years of
post-war reconstruction, increasing welfare and food se-
curity. However, evidence from younger cohorts suggests
that this development has not yet ceased and that even cur-
rent teenagers are taller and more obese than teenagers a
decade ago.31
A recent analysis from the CARDIA study32 showed
that not only the attained level, but also the duration of
overall and abdominal obesity, were associated with
coronary artery calcification indicating that subsequent
birth cohorts may be at elevated cardiovascular risk at a
younger age.
We showed that increasing abdominal obesity affects
both sexes similarly, and confirmed previous findings
that BMI levels in men are catching up with those in
women.12,13
A previous study on BMI trajectories reported that age-
related increases in BMI are underestimated using solely
cross-sectional data.14 In addition to this, we argue that
using longitudinal analyses without appropriate adjust-
ment for secular trends might also lead to biased estimates
as a consequence of large differences between different
birth cohorts.
Blood pressure
Our results are in line with the current understanding that
SBP rises from mid to late adulthood, whereas DBP peaks
around age 50 years and then starts to decline as a result of
B
Figure 1 A,B. Continued.
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Table 4A, B. Sequential cross-sectional analysis (age group: 57–61 years). Secular trends of lipid-lowering and antihypertensive
medication and smoking habits in men (A) and women (B)
A
Men Phase 3 1991–94 Phase 5 1997–99 Phase 7 2002–04 Phase 9 2007–09
Current smoker (%) 8.5 8.8 8.7 7.9
Lipid treatment (%) 1.4 4.1 10.6 24.0
Antihypertensive treatment (%) 12.4 15.2 21.9 28.0
B
Women Phase 3 1991–94 Phase 5 1997–99 Phase 7 2002–04 Phase 9 2007–09
Current smoker (%) 15.9 10.6 11.3 4.7
Lipid treatment (%) 2.0 4.1 7.9 19.9
Antihypertensive treatment (%) 16.9 20.9 20.9 24.8
A
Figure 2A, B. Longitudinal trajectory analysis. Age-related trajectories (in years) of cardiovascular risk factors in men (A) and women (B) with adjust-
ment for four different birth cohorts: 1933 (n), 1938 (^), 1943 (~), 1948 () and unadjusted (– – –).
(continued)
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increasing aortic and small vessel stiffness.33,34 These pre-
vious reports were also based on longitudinal studies, but
did not consider secular trends. By explicitly modelling tra-
jectories for different birth cohorts, we were able to show
that DBP levels are generally lower for younger cohorts. In
contrast, the dynamics of SBP trend were not consistent.
Although the results of mean trajectory analyses showed a
declining trend in women’s SBP (see Figure 2), the quantile
regression models suggest that this was mainly driven by
changes between the last two phases. Both our sequential
cross-sectional and trajectory analyses confirm the magni-
tude of DBP drop during the past 25 years and also with
ageing. This drop appears to be starting earlier in life in
younger generations. As DBP decreases faster across gener-
ations compared with SBP, a widening gap between SBP
and DBP develops leading to a larger and faster increase of
pulse pressure with age in younger compared with older
cohorts, especially among men. As pulse pressure is an
independent determinant of coronary heart disease (CHD)
risk35and DBP has been shown to have a negative associ-
ation with CHD risk after the age of 60 years,36 caution is
required when interpreting secular trends in blood
pressure.
Cholesterol
Previous studies have reported that TC levels are
declining in high-income countries9 including the USA4
and England,37 An earlier report from the Whitehall II
study,24 in line with reports from other developed coun-
tries,38 found that the decline in LDL cholesterol could
not be fully attributed to increasing use of lipid-lowering
medication and that improvements in diet play a signifi-
cant role.
B
Figure 2A, B. Continued.
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We confirm these earlier observations by reporting a
progressive left-shift of the entire TC distribution.
Although the observed decline may be at least partially due
to the wider use of statins in the past decades, particularly
in the elderly, this could not explain a decreasing trend in
the lower extremes of the distribution. This probably indi-
cates that secular trends in other factors (e.g. diet, lifestyle)
may have played an important role. We also have to note
that medication use increased both with age and calendar
year, leading to younger generations being more likely to
get lipid-lowering medication earlier in their life.
The effect of secular trends on cholesterol levels was so
large in the Whitehall II study that the unadjusted age-
related trajectory is clearly biased and underestimates TC
levels in late adulthood. This implies that an individual’s
multiple measurements over a longer period should not be
compared with population average trajectories without ad-
justment for the birth cohort effect. The magnitude of secu-
lar trends in cholesterol levels over the past three decades
also makes this a particularly challenging period for the
study of the isolated effects of ageing on cholesterol levels.
We observed a positive HDL cholesterol trend, but it
was very modest compared with changes seen in TC levels.
In particular, it seems that younger generations of women
have more favourable HDL levels throughout later middle
age, reflected by higher and steeper trajectories compared
with earlier birth cohorts.
Strengths
The key strength of our analysis was that we could study
the effect of secular trends and ageing on several cardiovas-
cular risk factors simultaneously in a relatively large popu-
lation-scale sample with up to five repeated measurements
over a 25-year period. Contrary to the common approach
of reporting average values and standard deviations, we
applied quantile regression which is well suited to highlight
changes in distribution characteristics.
Limitations
Loss to follow-up is a critical question when analysing
data from a longitudinal study with a long follow-up
period. There is no test to determine whether data are
missing at random (MAR) or missing not at random
(MNAR); thus both cases should be considered. If the
MAR assumption holds, likelihood-based methods give
valid estimates. If the missingness pattern is MNAR, sensi-
tivity analyses should be applied.39 In this study, such ana-
lyses replicated the main findings, suggesting that our
results were robust (data not shown). Standardization
of laboratory and other measurements is a recognized
problem. The changes in blood pressure measurement
device is an unlikely cause of the secular trend we showed,
as AOD produces slightly higher values than MRZ.40
Although all labs participated in the National External
Quality Assurance Scheme for TC and HDL, we cannot en-
tirely exclude standardization issues. The 57–61 age group
was arbitrarily chosen, so our conclusions about risk factor
distribution characteristics are not general for adulthood.
Sex differences could be biased by the uneven distribution
of men and women across employment grades. Previous
studies showed lower mortality rates41 and systolic blood
pressure trajectories,33 but similar BMI trajectories33 in
our occupational cohort compared with population-based
cohorts. Although it is likely that other risk factor levels
may also be slightly more favourable in the Whitehall II co-
hort, this does not imply that secular trends are also more
favourable.
Conclusion
We showed in an occupational cohort of British civil servants that
the past three decades brought strong and heterogeneous secular
trends in obesity, blood pressure and lipid levels. Decreasing CVD
mortality rates in the UK suggest that negative trends in obesity are
counterbalanced by favourable changes in blood pressure and chol-
esterol levels. The disparity of the trends indicates that the relative
importance of these risk factors is likely to change over time. This
observation has potential implications for the way we assess global
CVD risk based on risk scores, highlighting the need to reassess the
calibration of component weights on a regular basis. Our findings
also suggest that more detailed models of risk factor progression
may be needed to help track the development not only of average
levels but also changing risk factor distributions in the population.
Not accounting for secular trends may cause biased estimates in lon-
gitudinal analyses of age-related risk factor trajectories.
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